An interventional study of non-drug intervention in Depressive Disorder, sponsored by Central South University. Completed at 1 site in China. Open to participants aged 16 Years to 34 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-21.
Sponsored by Central South University · Not applicable, Interventional, and Treatment
Mindfulness training, relaxation training, and cerebellar electrical stimulation were used to intervene in the cognitive function of healthy individuals and individuals with first episode depression
In this proposed study,the investigators will evaluate the effects of different non-pharmacological interventions (physical/psychological) on emotion-related cognitive function.This project will use a variety of intervention methods to conduct research in healthy individuals and patients with mood disorders. The main intervention methods include: (1) mindfulness training;(2) relaxation training;(3) cerebellar electrical stimulation.
The study will recruit 80 healthy subjects and 40 first-episode depression patients. The study consisted of three steps: First, subjects filled in personal data and completed the first screening, randomly assigned groups, and filled in the pre-intervention questionnaire;Second, give a one-time non-drug intervention (mindfulness training, relaxation training or cerebellar electrical stimulation);Step 3: After the intervention, the subjects filled in the post-intervention questionnaire and completed the cognitive task test.Clinical efficacy and safety assessment will be done at first time. The specific aims are to evaluate the effect of non-drug therapy on cognitive function in healthy individuals and patients with first episode depression. and the behavior was evaluated by cognitive function task.
4,847 studies on the registry are indexed under Depressive Disorder; 509 are open to participants now.
This study's enrollment of 120 is above the median of 80 across 3,997 interventional studies indexed under Depressive Disorder.
Browse Depressive Disorder studies →Central South University is the lead sponsor of 131 studies on the registry; 29 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
-
Healthy individuals group:
First episode depression group:
Exclusion Criteria:
subjects are randomly divided into the intervention group. and they will be given a one-time non-drug intervention(mindfulness training, relaxation training or electrical cerebellar stimulation).
Other: non-drug intervention
subjects are randomly divided into the control group and regularly followed up.
mindfulness training, relaxation training, or electrical cerebellar stimulation
The change of mindfulness training on cognitive function in healthy individuals
Cognitive function are measured by Faces Emotion Recognition Task
Time frame: baseline
The change of mindfulness training on cognitive function in patients with first episode depression
Cognitive function are measured by Emotional Categorisation Task
Time frame: baseline
The change of cerebellar electrical stimulation on cognitive function in healthy individuals
Cognitive function are measured by Emotional Recall Task
Time frame: baseline
Ran from Jul 2020 to primary completion in Jun 2022, 23 months.
Of 1,212 non-industry interventional studies with no phase under Depressive Disorder, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 43. This study's 23 months is close to that.
Counting every sponsor, half of 1,273 studies reached it within 23 months; a quarter within 13 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.